Abstract
Despite their presence in many tissues and their potential implication in various disease states, low-voltage activated T-type calcium channels (T-channels) have only recently become targets of interest. Unfortunately, the lack of selective T-channel blockers has hampered further characterisation of these channels. The recent availability of cloned T-channels, the CaV3 proteins, facilitates identification of novel T-channel blockers. Also, studies performed in knockout animals have fostered novel interest. Selective inhibition of T-channels may have clinical importance in cardiovascular diseases, some forms of epilepsy, sleep disorders, pain and possibly cancer. This review focuses on novel research approaches to discover potent and selective T-channel modulators. These molecules may be potential drugs for treating human diseases, as well as important tools to decipher the physiological role of these channels.
Acknowledgements
The work performed in the laboratory is supported by CNRS, INSERM and grants from Agence Nationale pour la Recherche (ANR N° 06-NEURO-035-01) and Association Française contre les Myopathies (AFM). The authors thank Leigh Anne Swayne and Emmanuel Bourinet for critical reading of the manuscript.